SECOND EXTENSION - GRANTED
granted
on 28 Jun 2024
Last Applicant/ Owned by
411 SWEDELAND ROAD
KING OF PRUSSIA
PA
19406
Serial Number
97502573 filed on 14th Jul 2022
Registration Number
N/A
Correspondent Address
Joshua M. Gerben, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
PRECISION PLASMIDS
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services in the field of production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Manufacturing services for others in the fields of pharmaceutical preparations, biopharmaceutical preparations, biologics, drug products, DNA plasmids, advanced therapeutic medicinal products (ATMPs), principally cell and gene therapies intended for research, clinical and commercial use in humans for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting; production of cell lines for others using lentivirus technology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97502573
Mark Type
No Service Mark
Attorney Docket Number
No 07768-0043
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 28th Jun 2024 | SOU EXTENSION 2 GRANTED |
| 28th Jun 2024 | SOU EXTENSION 2 FILED |
| 28th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 15th Nov 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Nov 2023 | SOU EXTENSION 1 GRANTED |
| 13th Nov 2023 | SOU EXTENSION 1 FILED |
| 13th Nov 2023 | SOU TEAS EXTENSION RECEIVED |
| 04th Jul 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |